Immunomodulatory effects of selank in patients with anxiety-asthenic disorders
Uchakina ON, Uchakin PN, Miasoedov NF, et al. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova 2008;108:71-75.
What it found
In cultured blood cells from patients with depression, Selank suppressed IL-6 gene expression. In patients with generalised anxiety disorder and neurasthenia, 14 days of Selank was followed by shifts in the balance of Th1 and Th2 cytokines.
Limitations
Article in Russian. Number of patients and control conditions not given in the abstract. Measures immune markers, not symptoms.
Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.